Delta-Fly Pharma Inc
TSE:4598
Delta-Fly Pharma Inc
TSE:4598
Price:
739 JPY
1.23%
Market Closed
Updated:
May 2, 2024
Delta-Fly Pharma Inc
Cash from Financing Activities
|
Delta-Fly Pharma Inc
Cash from Financing Activities Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Delta-Fly Pharma Inc
TSE:4598
|
Cash from Financing Activities
¥882.6m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Cash from Financing Activities
¥10.7B
|
CAGR 3-Years
137%
|
CAGR 5-Years
54%
|
CAGR 10-Years
11%
|
|
|
PeptiDream Inc
TSE:4587
|
Cash from Financing Activities
¥264.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Cash from Financing Activities
-¥5.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Financing Activities
-¥535k
|
CAGR 3-Years
33%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Financing Activities
¥202.6m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Delta-Fly Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
119.9m
JPY
119.9m
JPY
Based on the financial report for Mar 31, 2022, Delta-Fly Pharma Inc's Cash from Financing Activities amounts to 119.9m JPY.
What is Delta-Fly Pharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-67%
-67%
Over the last year, the Cash from Financing Activities growth was -86%. The average annual Cash from Financing Activities growth rates for Delta-Fly Pharma Inc have been -67% over the past three years .
You don't have any saved screeners yet
